BBI-10

N/A

Report date: 2022/02/11 09:56:01
NME

Base Information

Drug NameBBI-10
Drug Alias NameBBI-10
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionStimulator of interferon genes inhibitors
TargetsStimulator of interferon genes
Therapy Area/IndicationsHereditary Autoinflammatory Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCarna Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesFresh Tracks Therapeutics IncCarna Biosciences Inc
Inactive CompaniesN/A
Active IndicationsHereditary Autoinflammatory Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A